Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 12;8(5):1320-1321.
doi: 10.1182/bloodadvances.2023012297.

Add-on erythropoietin in autoimmune hemolytic anemia

Miriam M Moser  1 , Bernd Jilma  1
Affiliations
Editorial

Add-on erythropoietin in autoimmune hemolytic anemia

Miriam M Moser et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: Reimbursement for scientific advice and expenses related to presentations was provided to B.J. by Sanofi and Sobi. M.M.M. declares no competing financial interests.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Fattizzo B, Pedone GL, Brambilla C, et al. Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis. Blood Adv. 2024;8(5):1322–1327. - PMC - PubMed
    1. Berentsen S, Barcellini W. Autoimmune Hemolytic Anemias. N Engl J Med. 2021;385(15):1407–1419. - PubMed
    1. Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2020;41 - PubMed
    1. Gelbenegger G, Berentsen S, Jilma B. Monoclonal antibodies for treatment of cold agglutinin disease. Expet Opin Biol Ther. 2023;23(5):395–406. - PubMed
    1. Berentsen S, Barcellini W, D’Sa S, Jilma B. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom? Immunotherapy. 2022;14(15):1191–1204. - PubMed

MeSH terms